Figure 2.
Bullous pemphigoid secondary to pembrolizumab. Biopsy shows perivascular eosinophils and vacuolar alteration along the junction. Bullae were not present histologically in the biopsy specimen. DIF showed deposition of C3 and IgG along the junction (not shown). Clinically, the patient had intact and eroded bullae on erythematous base.